Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest

The results of a retrospective analysis, of data from a large group patients with chronic myeloid leukemia (CML) treated with frontline Imatinib mesylate (Innovator/Generic) at a single institution between 2008 and 2014 showed comparable efficacy and safety.

Source: Clinical Lymphoma, Myeloma and Leukemia - May 10, 2017 Category: Hematology Authors: Madhav Danthala, Sadashivudu Gundeti, Siva Prasad Kuruva, Krishna Chaitanya Puligundla, Praveen Adusumilli, Ashok Pillai Karnam, Stalin Bala, Meher Lakshmi Konatam, Lakshmi Srinivas Maddali, Raghunadha Rao Digumarti Source Type: research